Page last updated: 2024-08-18

xanthenes and Disease Models, Animal

xanthenes has been researched along with Disease Models, Animal in 73 studies

Research

Studies (73)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.37)18.7374
1990's2 (2.74)18.2507
2000's23 (31.51)29.6817
2010's37 (50.68)24.3611
2020's10 (13.70)2.80

Authors

AuthorsStudies
Bartoszek, A; Binienda, A; Dziedziczak, K; Fabisiak, A; Fichna, J; Kordek, R; Krajewska, JB; Makaro, A; Mosińska, P; Niewinna, K; Salaga, M; Świerczyński, M; Talar, M; Tarasiuk, A1
Ciapała, K; Kwiatkowski, K; Makuch, W; Mika, J; Pawlik, K; Piotrowska, A; Popiolek-Barczyk, K1
Hoshino, T; Matsuzawa, SI; Takahashi, R1
Campos, MM; Costa, KM; da Costa, JC; Dagnino, APA; Freitas, RDS; Greggio, S; Muradás, TC; Rost, FL; Venturin, GT1
Alarabi, AB; Ali, HEA; Alshbool, FZ; Hernandez, KR; Hinojos, V; Karim, ZA; Khasawneh, FT; Lozano, PA; Montes Ramirez, JE1
Gong, YF; Huang, TY; Huang, XY; Liu, XC; Wang, ZZ; Zhang, XM1
Pałucha-Poniewiera, A; Podkowa, K; Rafało-Ulińska, A1
Ding, Z; Jing, F; Li, Y; Lu, B; Song, X; Tang, Z; Wu, H1
Kang, H; Kim, KJ; Lee, J; Lee, Y; Oh, E; Park, C; Park, KH; Son, YJ; Wang, W; Woo, GE1
Jing, XY; Li, LF; Li, ZL; Liu, YJ; Wang, Y; Zou, HW1
Atanasov, AG; Breuss, JM; Dirsch, VM; Heiss, EH; Jiang, B; Liu, R; Liu, W; Schachner, D1
Blaxall, BC; Kamal, FA; Lorenz, JN; Molkentin, JD; Nieman, ML; Sargent, MA; Travers, JG; Valiente-Alandi, I1
Ito, Y; Kariya, T; Maruyama, S; Matsukawa, Y; Mizuno, M; Nishimura, H; Sakata, F; Suzuki, Y; Takei, Y1
Li, G; Liu, Y; Yan, D; Zhang, H; Zhang, Y; Zhao, L1
Ikutomo, M; Muramatsu, K; Niwa, M; Shimo, S; Tamaki, T1
Kreiner, G; Mika, J; Nalepa, I; Piotrowska, A; Rojewska, E; Zychowska, M1
Chaki, S; Iijima, M; Koike, H3
Hara, T; Ide, S; Kaneda, K; Koseki, K; Maruyama, C; Minami, M; Naka, T; Ohno, A; Tamano, R; Yoshioka, M1
Baamonde, A; Hidalgo, A; Lastra, A; Meana, Á; Menéndez, L; Pevida, M1
Bin, L; Cheng, P; Dong, C; Fenggen, Y; Guanghui, W; Hui, C; Jingjing, S; Mei, W; Meiling, S; Qinglin, L; Xiaoshan, W; Yawen, H; Zhiwu, C1
Chan, MH; Chen, HH; Chiang, CC; Chiu, HY; Lee, MY1
Blaxall, BC; Hammes, SR; Kamal, FA; Mickelsen, DM; Moalem, J; Smrcka, AV; Travers, JG; Wegman, KM1
Chaki, S; Koike, H1
Diao, Y; Li, H; Li, X; Shan, L; Wang, H; Yin, J; Yue, R; Zhang, J; Zhang, S; Zhang, W1
Bai, G; Cao, DY; Ji, Y; Traub, RJ1
Benn, A; Robinson, ES1
Dong, W; Ji, X; Liang, J; Liu, KJ; Luo, Y; Qi, Z; Shi, W; Zhao, Y1
Ago, Y; Hasebe, S; Hashimoto, H; Matsuda, T; Nishiyama, S; Oka, S; Onaka, Y; Takuma, K1
Filipek, B; Gałuszka, A; Kazek, G; Kij, A; Marona, H; Olczyk, A; Pytka, K; Rapacz, A; Sapa, J; Siwek, A; Walczak, M; Waszkielewicz, A1
Altamirano, J; Borja-Villa, C; García, N; Pérez-Treviño, J; Pérez-Treviño, P1
Awasthi, S; Bossuyt, J; Chan, JW; Chen, YJ; Chen-Izu, Y; Chiamvimonvat, N; Izu, LT; Jian, Z; Lam, KS; Landas, T; Lerner, A; Lieu, DK; Mao, Z; Matthews, DL; Shimkunas, R; Woldeyesus, R; Wood, BM1
Andrade, PB; Guedes-Dias, P; Leitão-Rocha, A; Oliveira, JM; Pinho, BR; Quintas, C; Reis, SD; Santos, MM; Valentão, P1
Baamonde, A; Fernández-García, MT; González-Rodríguez, S; Hidalgo, A; Lastra, A; Llorián-Salvador, M; Menéndez, L1
Basta-Kaim, A; Budziszewska, B; Głombik, K; Holst, B; Młyniec, K; Nowak, G; Siwek, A; Skrzeszewski, J; Ślusarczyk, J; Trojan, E1
Feng, GH; Gao, LH; Li, L; Liu, HY; Liu, J; Liu, X; Niu, Y1
Connolly, KL; Detrick, MS; Horzempa, J; Jerse, AE; Schmitt, DM1
Ali, I; Amhaoul, H; Boets, S; Dedeurwaerdere, S; Janssens, P; Langlois, X; Van Eetveldt, A1
Egashira, T; Fukuda, K; Hashimoto, H; Hayashi, K; Hayashiji, N; Ito, S; Kashimura, S; Kodaira, M; Kunitomi, A; Kusumoto, D; Lachmann, M; Motoda, C; Nagai, T; Nakanishi, C; Sakata, K; Seki, T; Shimojima, M; Takei, M; Tohyama, S; Yamagishi, M; Yozu, G; Yuasa, S1
Arcella, A; Battaglia, G; Carpinelli, G; Ciceroni, C; De Maria, R; Giangaspero, F; Mastrantoni, E; Melchiorri, D; Mosillo, P; Nicoletti, F; Oliva, MA; Pallini, R; Ricci-Vitiani, L; Sale, P; Santoro, F1
Flannery, JG; Gregory-Evans, CY; Gregory-Evans, K; Guerin, K; Hodges, MD; Mackay, DS; Moosajee, M1
Steketee, JD; Xie, X1
Bianchi, E; Ghelardini, C; Norcini, M; Smrcka, A1
Bittner, GD; Boydston, EA; Britt, JM; Estler, CJ; Gbanaglo, MY; Kane, JR; Robinson, GL; Schallert, T; Spaeth, CS; Zuzek, A1
Bengtsen, CH; Christiansen, SH; Dencker, D; Fink-Jensen, A; Jensen, M; Loland, CJ; Petersen, JH; Sørensen, G; Weikop, P; Woldbye, DP; Wörtwein, G1
Almaguer-Villagrán, L; Arce-Paredes, P; Cid-Gutiérrez, JL; Jiménez-Arellanes, A; Mendoza-Aguilar, M; Rojas-Espinosa, O1
Bojang, P; Furukawa, T; Goldberg, AF; Gregg, RG; Hirschtritt, ME; Koike, C; McCall, MA; Nawy, S; Nishina, PM; Peachey, NS; Pearring, JN; Ray, TA; Shen, Y; Sturgill-Short, G1
Cole, ST; Dhar, N; Hartkoorn, RC; Mendoza-Losana, A; Sala, C; Zhang, M1
Aston-Jones, G; Fallon, RV; Hensley-Simon, M; Kalivas, PW; LaLumiere, RT; Mahler, SV; Tahsili-Fahadan, P; Thomas, C1
Chaki, S; Fukumoto, K; Iijima, M; Koike, H1
Mitsumoto, Y; Mori, A; Nakai, M; Watanabe, A1
Anderson, JJ; Baccei, CS; Bristow, LJ; Campbell, UC; Correa, LD; Lorrain, DS; Pinkerton, AB; Rodriguez, DE; Rowe, B; Schaffhauser, H; Varney, MA; Vernier, JM1
Chopin, C; Depontieu, F; Lancel, S; Marechal, X; Mordon, S; Neviere, R; Scherpereel, A; Tissier, S1
Grajkowska, E; Hirasawa, S; Kozikowski, A; Neale, JH; Wroblewska, B; Wroblewski, J; Yamamoto, T; Zhou, J1
Achilefu, S1
Ding, J; Fan, Y; Geng, M; Hu, J; Li, J; Wang, J; Xin, X; Yang, Z1
Bolwig, TG; Ernfors, P; Husum, H; Kokaia, M; Nanobashvili, A; Sørensen, AT; Sørensen, G; Woldbye, DP1
Battaglia, G; Biagioni, F; Bruno, V; Casciato, S; Ngomba, RT; Nicoletti, F; van Luijtelaar, EL; Willems-van Bree, E1
Ebinger, G; Hachimi-Idrissi, S; Michotte, Y; Sarre, S; Van Hemelrijck, A1
Carta, M; Mameli, M; Valenzuela, CF1
Griffey, KI; Johnson, BG; Knitowski, KM; McKinzie, DL; Monn, JA; Perry, KW; Rorick-Kehn, LM; Salhoff, CR; Schoepp, DD; Tizzano, JP; Witkin, JM1
Chen, W; He, J; Leng, X; Liao, X; Liu, J; Ma, H; Mai, W; Tao, J; Wang, L; Zhen, W1
Girardi, P; Giusti, P; Gruber, SH; Iacovelli, L; Mathé, AA; Matrisciano, F; Nicoletti, F; Panaccione, I; Tatarelli, R; Zusso, M1
Baker, DA; Haroutunian, V; Kristiansen, LV; Madayag, A; Meador-Woodruff, JH; Raju, I1
Castellano, RK; Ferreira, AJ; Gubala, V; Hernández Prada, JA; Katovich, MJ; Lampkins, AJ; Ostrov, DA; Qi, Y; Raizada, MK; Santos, RA; Shenoy, V1
Algarra, I; Gaforio, JJ; Garrido, F; Höglund, P; Ljunggren, HG; Pérez, M1
Ichiki, H; Ishihara, E; Komatsu, Y; Kubo, M; Miura, T; Okada, M; Tanigawa, K1
Carlen, PL; Frantseva, MV; Hwang, PA; Velazquez, JL1
Hashimoto, I; Ichiki, H; Ishida, T; Ishihara, E; Iwamoto, N; Kato, M; Komatsu, Y; Kubo, M; Miura, T; Okada, M; Tanigawa, K1
Bringmann, A; Faude, F; Francke, M; Goczalik, I; Grosche, J; Milenkovic, I; Pannicke, T; Reichenbach, A; Uckermann, O; Uhlmann, S; Weick, M; Wiedemann, P1
Cai, Z; Lin, S; Rhodes, PG1
Lämmler, G; Rudolph, R; Schuster, J; Zahner, H1

Reviews

2 review(s) available for xanthenes and Disease Models, Animal

ArticleYear
Multimodal SHG-2PF Imaging of Microdomain Ca2+-Contraction Coupling in Live Cardiac Myocytes.
    Circulation research, 2016, 01-22, Volume: 118, Issue:2

    Topics: Aniline Compounds; Animals; Cardiomyopathies; Disease Models, Animal; Excitation Contraction Coupling; Fluorescent Dyes; Kinetics; Male; Mechanotransduction, Cellular; Membrane Microdomains; Mice; Microscopy, Confocal; Microscopy, Fluorescence, Multiphoton; Multimodal Imaging; Myocardial Contraction; Myocytes, Cardiac; Rats, Sprague-Dawley; Sarcomeres; Stress, Mechanical; Xanthenes

2016
Lighting up tumors with receptor-specific optical molecular probes.
    Technology in cancer research & treatment, 2004, Volume: 3, Issue:4

    Topics: Animals; Bombesin; Carbocyanines; Carrier Proteins; Cell Membrane; Coloring Agents; Contrast Media; Diagnostic Imaging; Disease Models, Animal; Epidermal Growth Factor; Fluorescent Dyes; Folic Acid; Humans; Light; Models, Chemical; Models, Molecular; Molecular Probes; Neoplasms; Neurotensin; Peptides; Photosensitizing Agents; Somatostatin; Xanthenes

2004

Other Studies

71 other study(ies) available for xanthenes and Disease Models, Animal

ArticleYear
Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis.
    Molecules (Basel, Switzerland), 2021, Nov-11, Volume: 26, Issue:22

    Topics: Aniline Compounds; Animals; Butyrates; Colitis; Disease Models, Animal; Drug Synergism; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Inflammation; Ligands; Male; Mice; Mice, Inbred BALB C; Naloxone; Narcotic Antagonists; Peroxidase; Receptors, G-Protein-Coupled; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Sulfonamides; Thiophenes; Xanthenes

2021
The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
    Immunology, 2020, Volume: 159, Issue:4

    Topics: Analgesics; Animals; Buprenorphine; Calcium-Binding Proteins; Chemokine CCL2; Disease Models, Animal; Drug Synergism; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Interleukin-18; Interleukin-1beta; Interleukin-6; Male; Microfilament Proteins; Morphine; Neuralgia; Nociception; Peroxidase; Protein Isoforms; Rats; Rats, Wistar; Receptors, CCR1; Sciatic Nerve; Signal Transduction; Xanthenes

2020
6-Deoxyjacareubin, a natural compound preventing hypoxia-induced cell death, ameliorates neurodegeneration in a mouse model of familial amyotrophic lateral sclerosis.
    Neuroscience research, 2021, Volume: 163

    Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Death; Disease Models, Animal; Hypoxia; Mice; Mice, Transgenic; Motor Neurons; Pyrans; Superoxide Dismutase; Superoxide Dismutase-1; Xanthenes

2021
Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
    American journal of physiology. Endocrinology and metabolism, 2020, 11-01, Volume: 319, Issue:5

    Topics: alpha-Linolenic Acid; Animals; Benzoates; Biphenyl Compounds; Body Weight; Cachexia; Carcinoma, Lewis Lung; Disease Models, Animal; Docosahexaenoic Acids; Methylamines; Mice; Muscle, Skeletal; Neoplasm Transplantation; Phenylpropionates; Propionates; Pyrimidines; Receptors, G-Protein-Coupled; Sulfonamides; Xanthenes

2020
The G-protein βγ subunits regulate platelet function.
    Life sciences, 2020, Dec-01, Volume: 262

    Topics: Animals; Blood Platelets; Clot Retraction; Disease Models, Animal; GTP-Binding Protein beta Subunits; GTP-Binding Protein gamma Subunits; Hemostasis; Humans; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction; Thrombosis; Xanthenes

2020
Scar-reducing effects of gambogenic acid on skin wounds in rabbit ears.
    International immunopharmacology, 2021, Volume: 90

    Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Anti-Inflammatory Agents; Cicatrix, Hypertrophic; Collagen; Cytokines; Disease Models, Animal; Ear; Female; Inflammation Mediators; Male; Neovascularization, Physiologic; Rabbits; Signal Transduction; Skin; Wound Healing; Wounds and Injuries; Xanthenes

2021
The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2021, 07-13, Volume: 109

    Topics: Amino Acids; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Ketamine; Male; Mice; Mice, Inbred C57BL; Motor Skills; Prefrontal Cortex; Receptors, Metabotropic Glutamate; Synaptosomes; Xanthenes

2021
Role of gambogenic acid in regulating PI3K/Akt/NF-kβ signaling pathways in rat model of acute hepatotoxicity.
    Bioscience, biotechnology, and biochemistry, 2021, Feb-24, Volume: 85, Issue:3

    Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Liver; Male; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Xanthenes

2021
Austalide K from the Fungus
    International journal of molecular sciences, 2021, May-23, Volume: 22, Issue:11

    Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Cell Differentiation; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression Regulation; Geologic Sediments; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Molecular Structure; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Osteoporosis; Penicillium; RANK Ligand; Tartrate-Resistant Acid Phosphatase; Xanthenes

2021
mGlu2/3 receptor in the prelimbic cortex is implicated in stress resilience and vulnerability in mice.
    European journal of pharmacology, 2021, Sep-05, Volume: 906

    Topics: Amino Acids; Animals; Depression; Disease Models, Animal; Humans; Male; Mice; Prefrontal Cortex; Receptors, Metabotropic Glutamate; Resilience, Psychological; Social Defeat; Stress, Psychological; Xanthenes

2021
Xanthohumol Blocks Proliferation and Migration of Vascular Smooth Muscle Cells in Vitro and Reduces Neointima Formation in Vivo.
    Journal of natural products, 2017, 07-28, Volume: 80, Issue:7

    Topics: Animals; Becaplermin; Cell Movement; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonoids; Humulus; MAP Kinase Signaling System; Mice; Molecular Structure; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Oxazines; Phosphorylation; Platelet-Derived Growth Factor; Propiophenones; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Signal Transduction; Wound Healing; Xanthenes

2017
Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Journal of the American College of Cardiology, 2017, Aug-22, Volume: 70, Issue:8

    Topics: Animals; Disease Models, Animal; Disease Progression; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Mice; Mice, Knockout; Myocardial Ischemia; Myocardium; Myofibroblasts; Ventricular Remodeling; Xanthenes

2017
TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    American journal of physiology. Renal physiology, 2018, 02-01, Volume: 314, Issue:2

    Topics: Aged; Aged, 80 and over; Amino Acids; Angiogenesis Inhibitors; Animals; Cell Line; Disease Models, Animal; Female; Fibroblasts; Humans; Male; Middle Aged; Neovascularization, Pathologic; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Xanthenes

2018
Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Journal of the American Society of Hypertension : JASH, 2017, Volume: 11, Issue:12

    Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Endothelium, Vascular; Enzyme Activators; Humans; Hypertension, Pulmonary; Imidazoles; Leucine; Lung; Male; Monocrotaline; Naphthalenes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Phosphorylation; Pulmonary Artery; Pyrans; Rats; Rats, Sprague-Dawley; Signal Transduction; Specific Pathogen-Free Organisms; Spiro Compounds; Xanthenes

2017
Effect of streptozotocin-induced diabetes on motor representations in the motor cortex and corticospinal tract in rats.
    Brain research, 2018, 02-01, Volume: 1680

    Topics: Action Potentials; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; Electric Stimulation; Hindlimb; Ketosis; Male; Motor Cortex; Motor Disorders; Neural Conduction; Neurons; Pyramidal Tracts; Rats; Rats, Wistar; Xanthenes

2018
Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine.
    Frontiers in immunology, 2018, Volume: 9

    Topics: Analgesics, Opioid; Animals; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokines, CC; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Humans; Macrophage Inflammatory Proteins; Macrophages; Mice; Morphine Derivatives; Neuralgia; Neurons; Receptors, CCR1; Xanthenes

2018
Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
    Behavioural brain research, 2013, Jun-01, Volume: 246

    Topics: Amino Acids; Analysis of Variance; Animals; Central Nervous System Stimulants; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Interactions; Excitatory Amino Acid Antagonists; Immobility Response, Tonic; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Swimming; Xanthenes

2013
Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Apr-03, Volume: 33, Issue:14

    Topics: Action Potentials; Affective Symptoms; Analysis of Variance; Aniline Compounds; Animals; Arginine; Corticotropin-Releasing Hormone; Cyclohexanes; Disease Models, Animal; Excitatory Amino Acid Antagonists; Formaldehyde; GABA Antagonists; Hormone Antagonists; Hormones; In Vitro Techniques; Kynurenic Acid; Male; Membrane Potentials; Microdialysis; Neurons; Neuropeptide Y; Pain; Pain Measurement; Peptide Fragments; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Xanthenes

2013
Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 107

    Topics: Amino Acids; Animals; Corticosterone; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Drug Administration Schedule; Immobility Response, Tonic; Injections, Subcutaneous; Ketamine; Male; Rats; Receptors, Metabotropic Glutamate; Xanthenes

2013
The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
    Neuroscience, 2014, Feb-14, Volume: 259

    Topics: Analysis of Variance; Animals; Bone Neoplasms; Cell Line, Tumor; Chemokine CCL5; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Gene Expression Regulation, Neoplastic; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Pain Measurement; Pain Threshold; Peptide T; Receptors, CCR1; Xanthenes

2014
Gambogenic acid kills lung cancer cells through aberrant autophagy.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Knockdown Techniques; HeLa Cells; Humans; Lung Neoplasms; Lysosomes; Male; Membrane Proteins; Mice; Phagosomes; Terpenes; Xanthenes; Xanthones; Xenograft Model Antitumor Assays

2014
N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
    Neuropharmacology, 2014, Volume: 81

    Topics: Acetylcysteine; Action Potentials; Amino Acids; Amphetamines; Animals; Benzoates; Bicuculline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Early Growth Response Protein 2; Excitatory Amino Acid Antagonists; Free Radical Scavengers; GABA-A Receptor Antagonists; Glycine; Hallucinations; Hallucinogens; Male; Mice; Proto-Oncogene Proteins c-fos; Receptors, Metabotropic Glutamate; Xanthenes

2014
Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.
    Journal of the American College of Cardiology, 2014, Jun-17, Volume: 63, Issue:23

    Topics: Adrenal Glands; Animals; Cells, Cultured; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; G-Protein-Coupled Receptor Kinase 2; Heart; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Stroke Volume; Treatment Outcome; Xanthenes

2014
Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
    Behavioural brain research, 2014, Sep-01, Volume: 271

    Topics: Adaptation, Psychological; Amino Acids; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Ketamine; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Stress, Psychological; Swimming; Time Factors; Xanthenes

2014
Jacarelhyperol A induced apoptosis in leukaemia cancer cell through inhibition the activity of Bcl-2 proteins.
    BMC cancer, 2014, 09-22, Volume: 14

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Binding Sites; Caspases; Cell Line, Tumor; Cytochromes c; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia; Mice; Models, Molecular; Molecular Conformation; Protein Binding; Protein Multimerization; Proto-Oncogene Proteins c-bcl-2; Xanthenes; Xenograft Model Antitumor Assays

2014
Epigenetic upregulation of metabotropic glutamate receptor 2 in the spinal cord attenuates oestrogen-induced visceral hypersensitivity.
    Gut, 2015, Volume: 64, Issue:12

    Topics: Acetylation; Amino Acids; Animals; Disease Models, Animal; Epigenesis, Genetic; Estradiol; Estrogens; Female; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Nociception; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; RNA, Messenger; Spinal Cord; Up-Regulation; Viscera; Visceral Pain; Vorinostat; Xanthenes

2015
Investigating glutamatergic mechanism in attention and impulse control using rats in a modified 5-choice serial reaction time task.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: Amino Acids; Animals; Attention; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Impulsive Behavior; Male; N-Methylaspartate; Prefrontal Cortex; Rats; Reaction Time; Xanthenes

2014
Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model.
    Experimental neurology, 2015, Volume: 272

    Topics: Analysis of Variance; Animals; Brain; Cholinesterase Inhibitors; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Membrane Potential, Mitochondrial; Mitochondria; Oxygen; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Xanthenes; Zinc

2015
The Female Encounter Test: A Novel Method for Evaluating Reward-Seeking Behavior or Motivation in Mice.
    The international journal of neuropsychopharmacology, 2015, May-29, Volume: 18, Issue:11

    Topics: Amino Acids; Animals; Antidepressive Agents, Second-Generation; Castration; Choice Behavior; Corticosterone; Depressive Disorder; Disease Models, Animal; Equipment Design; Estrous Cycle; Excitatory Amino Acid Antagonists; Female; Fluvoxamine; Lipopolysaccharides; Male; Mice; Motivation; Nucleus Accumbens; Psychological Tests; Reward; Social Behavior; Social Isolation; Xanthenes

2015
The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
    European journal of pharmacology, 2015, Oct-05, Volume: 764

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Rotarod Performance Test; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Swimming; Xanthenes; Xanthones

2015
Changes in T-Tubules and Sarcoplasmic Reticulum in Ventricular Myocytes in Early Cardiac Hypertrophy in a Pressure Overload Rat Model.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 37, Issue:4

    Topics: Aniline Compounds; Animals; Calcium; Calcium Signaling; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fluorescence Recovery After Photobleaching; Fluorescent Dyes; Ions; Male; Microscopy, Confocal; Microtubules; Myocytes, Cardiac; Pressure; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Xanthenes

2015
Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
    Pharmacological research, 2016, Volume: 103

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Behavior, Animal; Benzamides; Diencephalon; Disease Models, Animal; Histone Deacetylase 1; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Indoles; Larva; Locomotion; Neurotoxins; Oxazines; Parkinson Disease, Secondary; Pyridines; RNA, Messenger; Tyrosine 3-Monooxygenase; Xanthenes; Zebrafish; Zebrafish Proteins

2016
Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice.
    Basic & clinical pharmacology & toxicology, 2016, Volume: 119, Issue:1

    Topics: Acute Pain; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Chemokine CCL3; Chemokine CCL5; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Freund's Adjuvant; Hyperalgesia; Inflammation; Male; Mice; Neutrophils; Receptors, CCR1; RNA, Messenger; Spinal Cord; Xanthenes

2016
Immune malfunction in the GPR39 zinc receptor of knockout mice: Its relationship to depressive disorder.
    Journal of neuroimmunology, 2016, Feb-15, Volume: 291

    Topics: Animals; Cell Proliferation; Cell Survival; Concanavalin A; Cytokines; Depressive Disorder; Disease Models, Animal; Female; Gene Expression Regulation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogens; Motor Activity; Organ Size; Oxazines; Receptors, G-Protein-Coupled; Spleen; Swimming; Thymocytes; Xanthenes

2016
Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity.
    Pharmaceutical biology, 2016, Volume: 54, Issue:9

    Topics: Administration, Oral; Animals; Biomarkers; Biotransformation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Kinetics; Mice; Molecular Structure; Oxonic Acid; Structure-Activity Relationship; Uric Acid; Xanthenes; Xanthine Oxidase; Xanthones

2016
Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo.
    International journal of antimicrobial agents, 2016, Volume: 48, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Disease Models, Animal; Female; Gonorrhea; Humans; Indicators and Reagents; Mice, Inbred BALB C; Neisseria gonorrhoeae; Oxazines; Treatment Outcome; Xanthenes

2016
Metabotropic glutamate receptor 2/3 density and its relation to the hippocampal neuropathology in a model of temporal lobe epilepsy in rats.
    Epilepsy research, 2016, Volume: 127

    Topics: Acute Disease; Amino Acids; Animals; Autoradiography; Chronic Disease; Cross-Sectional Studies; Disease Models, Animal; Disease Progression; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; Hippocampus; Kainic Acid; Male; Parietal Lobe; Radiopharmaceuticals; Rats, Wistar; Receptors, Metabotropic Glutamate; Thalamus; Time Factors; Tritium; Xanthenes

2016
Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient.
    Scientific reports, 2017, 03-14, Volume: 7

    Topics: Active Transport, Cell Nucleus; Angiotensin II; Aniline Compounds; Animals; Atrial Remodeling; Calcium; Cardiomegaly; Cytoplasm; Disease Models, Animal; Endothelin-1; Fluorescent Dyes; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; Membrane Proteins; Muscular Dystrophy, Emery-Dreifuss; Myocardium; Myocytes, Cardiac; Nuclear Envelope; Nuclear Proteins; Phenylephrine; Primary Cell Culture; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Ventricular Remodeling; Xanthenes

2017
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells.
    Neuropharmacology, 2008, Volume: 55, Issue:4

    Topics: Amino Acids; Animals; Bone Morphogenetic Protein Receptors; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glioma; Humans; Magnetic Resonance Imaging; Mice; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Phosphorylation; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes

2008
Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa.
    Experimental eye research, 2008, Volume: 87, Issue:3

    Topics: Aminoglycosides; Animals; Carrier Proteins; cis-trans-Isomerases; Codon, Nonsense; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroretinography; Eye Proteins; Fluorescent Dyes; Gentamicins; Mice; Mice, Mutant Strains; Rats; Rats, Transgenic; Retina; Retinitis Pigmentosa; Rhodopsin; Xanthenes

2008
Repeated exposure to cocaine alters the modulation of mesocorticolimbic glutamate transmission by medial prefrontal cortex Group II metabotropic glutamate receptors.
    Journal of neurochemistry, 2008, Volume: 107, Issue:1

    Topics: Amino Acids; Animals; Cocaine; Cocaine-Related Disorders; Cystine; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Glutamic Acid; Limbic System; Male; Neural Pathways; Prefrontal Cortex; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission; Synaptic Vesicles; Ventral Tegmental Area; Xanthenes

2008
Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.
    Journal of neurochemistry, 2009, Volume: 111, Issue:1

    Topics: Animals; Cyclohexanes; Disease Models, Animal; Drug Administration Routes; Drug Interactions; Exploratory Behavior; Gene Expression Regulation; GTP-Binding Protein beta Subunits; Hyperalgesia; Immunoprecipitation; Male; Mice; Mice, Knockout; Morphine; Pain Measurement; Pain Threshold; Periaqueductal Gray; Phospholipase C beta; Reaction Time; Receptors, Opioid, mu; Somatostatin; Xanthenes

2009
Polyethylene glycol rapidly restores axonal integrity and improves the rate of motor behavior recovery after sciatic nerve crush injury.
    Journal of neurophysiology, 2010, Volume: 104, Issue:2

    Topics: Action Potentials; Analysis of Variance; Animals; Axons; Disease Models, Animal; Locomotion; Male; Motor Activity; Neural Conduction; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Recovery of Function; Sciatic Neuropathy; Surface-Active Agents; Time Factors; Xanthenes

2010
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Neuropharmacology, 2011, Volume: 61, Issue:8

    Topics: Amino Acids; Analysis of Variance; Animals; Bridged Bicyclo Compounds; Depression; Dicarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Hindlimb Suspension; Ketamine; Male; Mice; Mice, Inbred ICR; Receptors, Metabotropic Glutamate; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Xanthenes

2011
Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice.
    Psychopharmacology, 2012, Volume: 222, Issue:4

    Topics: Animals; Animals, Outbred Strains; Cocaine; Cocaine-Related Disorders; Corpus Striatum; Cyclohexanes; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Female; Hyperkinesis; Male; Mice; Mice, Knockout; Nucleus Accumbens; Receptors, Neuropeptide Y; Reinforcement, Psychology; Self Administration; Xanthenes

2012
The use of the microplate alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:5

    Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Histocytochemistry; Indicators and Reagents; Leprostatic Agents; Liver; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium Infections; Mycobacterium lepraemurium; Oxazines; Plant Extracts; Xanthenes

2012
Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation.
    Journal of neurophysiology, 2012, Volume: 108, Issue:9

    Topics: Action Potentials; Amino Acid Sequence; Amino Acids; Animals; Capsaicin; Chromosome Mapping; Chromosomes, Mammalian; Dendrites; Disease Models, Animal; Exons; Eye Diseases, Hereditary; Genetic Diseases, X-Linked; Heterozygote; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation, Missense; Myopia; Night Blindness; Point Mutation; Retina; Retinal Bipolar Cells; Sequence Analysis, DNA; Threonine; TRPM Cation Channels; Xanthenes

2012
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Acetamides; Amino Acid Sequence; Animals; Antitubercular Agents; Clofazimine; Diarylquinolines; Disease Models, Animal; Drug Discovery; Drugs, Investigational; Female; Genetic Engineering; Latent Tuberculosis; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium tuberculosis; Oxazines; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Structure-Activity Relationship; Xanthenes

2012
Modafinil attenuates reinstatement of cocaine seeking: role for cystine-glutamate exchange and metabotropic glutamate receptors.
    Addiction biology, 2014, Volume: 19, Issue:1

    Topics: Amino Acid Transport System y+; Amino Acids; Analysis of Variance; Animals; Benzhydryl Compounds; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug-Seeking Behavior; Excitatory Amino Acid Antagonists; Extinction, Psychological; Glutamates; Male; Microdialysis; Microinjections; Modafinil; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Secondary Prevention; Self Administration; Wakefulness-Promoting Agents; Xanthenes

2014
Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Behavioural brain research, 2013, Feb-01, Volume: 238

    Topics: Amino Acids; Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depressive Disorder; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Receptor, trkB; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes

2013
1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.
    Experimental neurology, 2003, Volume: 179, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Benzimidazoles; Carbocyanines; Coloring Agents; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluorometry; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Mitochondria; Nerve Tissue Proteins; Oxazines; Oxidation-Reduction; Parkinsonian Disorders; Piperazines; Presynaptic Terminals; Rats; Rats, Wistar; Sodium Cyanide; Synaptosomes; Tyrosine 3-Monooxygenase; Xanthenes

2003
Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:9

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Analysis of Variance; Animals; Area Under Curve; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Humans; Hyperkinesis; In Vitro Techniques; Ketamine; Male; Microdialysis; Motor Activity; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Metabotropic Glutamate; Schizophrenia; Serotonin; Sulfur Isotopes; Time Factors; Trifluoroethanol; Xanthenes

2003
Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats.
    Journal of the American College of Cardiology, 2004, Jun-16, Volume: 43, Issue:12

    Topics: Animals; Biomarkers; Catalysis; Disease Models, Animal; Endothelium, Vascular; Endotoxemia; Enzyme Inhibitors; Fluorescent Dyes; Guanidines; I-kappa B Proteins; Leukocytes; Metalloporphyrins; Models, Cardiovascular; Myocarditis; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine; Xanthenes

2004
Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.
    The European journal of neuroscience, 2004, Volume: 20, Issue:2

    Topics: Amino Acids; Analgesics; Animals; Behavior, Animal; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Humans; Immunohistochemistry; Injections, Intravenous; Injections, Spinal; Nociceptors; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Protease Inhibitors; Proto-Oncogene Proteins c-fos; Rats; Reaction Time; Sciatic Neuropathy; Urea; Xanthenes

2004
Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms.
    Neuroscience letters, 2005, Feb-21, Volume: 374, Issue:3

    Topics: Adenosine Triphosphatases; Alkaloids; Analysis of Variance; Aniline Compounds; Animals; Behavior, Animal; Brain Chemistry; Calcium; Carbohydrates; Cell Count; Cell Death; Cell Line; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Escape Reaction; Glutathione Peroxidase; Hippocampus; Humans; Male; Mannans; Maze Learning; Memory Disorders; Muscarinic Antagonists; Neuroprotective Agents; Oligosaccharides; Rats; Rats, Wistar; Reaction Time; Scopolamine; Sesquiterpenes; Superoxide Dismutase; Swimming; Time Factors; Xanthenes

2005
Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
    Neurobiology of disease, 2005, Volume: 20, Issue:3

    Topics: Animals; Cells, Cultured; Convulsants; Cyclohexanes; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Hippocampus; Kainic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neurons; Neuropeptide Y; Organ Culture Techniques; Receptors, Neuropeptide Y; Synaptic Transmission; Xanthenes

2005
The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.
    Neuropharmacology, 2005, Volume: 49 Suppl 1

    Topics: Age Factors; Amino Acids; Analysis of Variance; Animals; Baclofen; Behavior, Animal; Blotting, Western; Brain; Brain Mapping; Circadian Rhythm; Cyclic AMP; Disease Models, Animal; Electroencephalography; Epilepsy, Absence; Excitatory Amino Acid Antagonists; GABA Agonists; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indoles; Male; Microdialysis; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Metabotropic Glutamate; Xanthenes

2005
Neuroprotective effect of N-acetyl-aspartyl-glutamate in combination with mild hypothermia in the endothelin-1 rat model of focal cerebral ischaemia.
    Journal of neurochemistry, 2005, Volume: 95, Issue:5

    Topics: Amino Acids; Animals; Blood-Brain Barrier; Brain Ischemia; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Endothelin-1; Hypothermia; Male; Microdialysis; Neuroprotective Agents; Rats; Rats, Wistar; Time Factors; Xanthenes

2005
Alcohol potently modulates climbing fiber-->Purkinje neuron synapses: role of metabotropic glutamate receptors.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Feb-15, Volume: 26, Issue:7

    Topics: Alanine; Animals; Aspartic Acid; Disease Models, Animal; Ethanol; Long-Term Synaptic Depression; Male; Nerve Fibers; Patch-Clamp Techniques; Purkinje Cells; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synapses; Xanthenes

2006
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
    Psychopharmacology, 2007, Volume: 193, Issue:1

    Topics: Amino Acids; Amphetamine; Animals; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cyclic S-Oxides; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mental Disorders; Mice; Molecular Structure; Motor Activity; Phencyclidine; Prefrontal Cortex; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Xanthenes

2007
Angiotensin-converting enzyme inhibitor improves force and Ca2 +--frequency relationships in myocytes from rats with heart failure.
    Acta cardiologica, 2007, Volume: 62, Issue:2

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aniline Compounds; Animals; Blotting, Western; Calcium-Binding Proteins; Disease Models, Animal; Fluorescent Dyes; Heart Failure; Heart Ventricles; Male; Microscopy, Confocal; Myocardial Contraction; Myocytes, Cardiac; Perindopril; Random Allocation; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger; Xanthenes

2007
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?
    Molecular psychiatry, 2007, Volume: 12, Issue:8

    Topics: Adjuvants, Pharmaceutic; Amino Acids; Animals; Antidepressive Agents, Tricyclic; Bridged Bicyclo Compounds, Heterocyclic; Depressive Disorder; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Agents; Hippocampus; Imipramine; In Vitro Techniques; Mice; Neurons; Rats; Rats, Inbred Strains; Receptor Cross-Talk; Receptors, Metabotropic Glutamate; Time Factors; Xanthenes

2007
Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:7

    Topics: Acetylcysteine; Aged; Aged, 80 and over; Amino Acids; Analysis of Variance; Animals; Behavior, Animal; Cell Line, Transformed; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Fluid; Female; Free Radical Scavengers; Glutamic Acid; Glycine; Humans; Interpersonal Relations; Male; Maze Learning; Microdialysis; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Xanthenes

2008
Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:5

    Topics: Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme Activators; Heart; Hypertension; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resorcinols; Structure-Activity Relationship; Xanthenes

2008
Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue.
    International journal of cancer, 1993, May-28, Volume: 54, Issue:3

    Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; G(M1) Ganglioside; Immune Sera; Killer Cells, Natural; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Spleen; Tilorone; Time Factors; Xanthenes; Xanthones

1993
New antidiabetic compounds, mangiferin and its glucoside.
    Biological & pharmaceutical bulletin, 1998, Volume: 21, Issue:12

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hyperinsulinism; Hypoglycemic Agents; Male; Mice; Xanthenes; Xanthones

1998
Free radical production correlates with cell death in an in vitro model of epilepsy.
    The European journal of neuroscience, 2000, Volume: 12, Issue:4

    Topics: Action Potentials; Aniline Compounds; Animals; Antioxidants; Bicuculline; Calcium; Cell Death; Disease Models, Animal; Epilepsy; Fluorescent Dyes; Free Radicals; GABA Antagonists; Glutathione; Hippocampus; Microscopy, Fluorescence; Nerve Degeneration; Organ Culture Techniques; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Rhodamines; Vitamin E; Xanthenes

2000
Antidiabetic activity of a xanthone compound, mangiferin.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2001, Volume: 8, Issue:2

    Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Magnoliopsida; Male; Mice; Phytotherapy; Plant Extracts; Xanthenes; Xanthones

2001
Upregulation of extracellular ATP-induced Müller cell responses in a dispase model of proliferative vitreoretinopathy.
    Investigative ophthalmology & visual science, 2002, Volume: 43, Issue:3

    Topics: Adenosine Triphosphate; Aniline Compounds; Animals; Calcium; Disease Models, Animal; Endopeptidases; Female; Hypertrophy; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Microscopy, Confocal; Neuroglia; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Rabbits; Receptors, Purinergic P2; Up-Regulation; Vitreoretinopathy, Proliferative; Xanthenes

2002
Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
    European journal of pharmacology, 2002, Feb-22, Volume: 437, Issue:3

    Topics: Amino Acids; Animals; Animals, Newborn; Brain; Carboxypeptidases; Cyclic AMP; Cycloleucine; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Hippocampus; Hypoxia-Ischemia, Brain; Neurons; Neuroprotective Agents; Organophosphorus Compounds; Propionates; Rats; Rats, Sprague-Dawley; Xanthenes

2002
[Pathophysiological and toxicological aspects of Schistosoma mansoni infection in Mastomys natalensis under treatment with Hycanthone].
    Zeitschrift fur Tropenmedizin und Parasitologie, 1973, Volume: 24, Issue:4

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Female; Glutamate Dehydrogenase; L-Lactate Dehydrogenase; Liver Diseases; Male; Mesylates; Mice; Mice, Inbred Strains; Oxidoreductases; Parasite Egg Count; Schistosoma; Schistosomiasis; Sorbitol; Xanthenes

1973